Navigation Links
Malaria: New Treatment is Upcoming
Date:1/16/2009

ROME, January 16 /PRNewswire/ -- The results of two new large scale trials show that the combination of dihydroartemisinin and piperaquine (DHA+PQP) not only is effective against uncomplicated malaria in a way which is comparable to other artemisinin-based combination therapies (ACTs), but it also protects patients against new infections for at least two months after treatment. The DHA/PQP combination is very well tolerated with no significant side effects.

These notable results were presented at the 57th Annual Meeting of the American Society of Tropical Medicine & Hygiene (ASTMH) held in New Orleans, Louisiana, USA, (December 7-11, 2008). The results demonstrate the benefits of a treatment which is effective against a neglected disease contracted by 400-500 million people worldwide every year and the cause of death of over 1 million people, sadly largely children under 5 in Sub-Saharan Africa.

"If not promptly and effectively treated, malaria can kill in just a few days after the onset of symptoms," said Prof. Umberto D'Alessandro, Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium, coordinator of one of the trials. "This novel medication expands the treatment arsenal available to us, delivers immediate benefits because it acts rapidly, and unquestionably provides help to the populations of Africa and Asia, who are the hardest hit by the disease, but also to Westerners who visit those countries for business or pleasure."

Developed by sigma-tau, the new ACT meets WHO clinical evidence-based treatment strategy recommendation as it is a medication combining in a single tablet the highly potent artemisinin-based active ingredient which does not stay long in the body with a second antimalarial which stays longer in the body. This combination treatment is to be taken only for three days and facilitates the mutual protection of the two active ingredients against drug resistance.
'/>"/>

SOURCE sigma-tau
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. BioTrends Releases TreatmentTrends(TM): US Nephrology, an Ongoing Syndicated Publication Providing Insight into Physician Perceptions and Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
2. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
3. Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
4. Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
5. Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia
6. Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM)
7. Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias
8. Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia
9. Vasomotor Symptoms? Create an Individual Treatment Plan for Your Patient
10. New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases
11. ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... COLUMBUS, Ohio, Nov. 30 The Ohio ... of the nation,s first minority business early-sta...eland December 3, is called "Transforming the Land...Early-Stage Capital Summit." It will feature sever... business leaders and local minority entrepreneurs...
(Date:11/30/2009)... NEW YORK, Nov. 30 The ... (MJFF) today announced $1.5 million in total awar...ially disease-modifying therapies for Parkinson,s ...Approaches to Drug Discovery for Parkinson,s Disea...rporation, plc (NYSE: ELN ), a neuroscience-base...
(Date:11/30/2009)...HICAGO, Nov. 30 Dr. Jessica Torren...hington University Medical Center in Washington, D...t-Specific Gamma Imaging (BSGI) in clinical practi...s of breast cancer today at the annual meeting of ...,, "The purpose of the exhibit was to demonstra...
(Date:11/30/2009)... PDS, a leader in providing smart and...announces Pajama Pathology®, evolutionizing wo...‘gold standard’ software used by 8 of ...but on a ‘cost per slide’ basis. , ...November 30, 2009 -- PDS has announced another evo...
Breaking Biology Technology:Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3
...Inc. (OTC Bulletin Board: TBIO) is canceling the f...omic Inc. Fourth Quarter 2008 Earnings Release, ...nesday, February 25, 2009 @ 5:00 p.m. Eastern, ... , , , Transgenomic will communicate by Press R...r the Fourth Quarter 2008 Earnings Release Confere...
...ioidentical hormones are superior to synthetic HRT...risk of breast cancer , , TORRANCE, Calif., Feb. ...shed in the Postgraduate Medical Journal, a leadin...ans, showed that bioidentical hormones are associa...ious than their synthetic counterparts. Conducted ...
...GeneraMedix, Inc. announced,today that it has ente...ed,formulation of epoprostenol sodium for the intr...on (PAH) to Actelion LTD., a biopharmaceutical com...tzerland. Financial terms of the deal,were not dis...mpany,s ongoing commitment to serving,the unique n...
Other Biology Technology:New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy 2New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy 3GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd. 2GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd. 3
(Date:12/1/2009)...d international research team has developed an inn...tion of solar cells. , Scientists at Monash Univ...universities of Wollongong and Ulm in Germany, hav...a three-fold increase in energy conversion efficie...ensitised solar cells. , Lead researcher Dr Udo...
(Date:12/1/2009)...among groups of people, research at the University...o and Harvard shows., Using longitudinal data fr...lth conditions for more than 60 years, a team of s...ir loneliness with others. Gradually over time, a ...fringes of social networks., We detected an extr...
(Date:11/30/2009)...s Ron Falta and Larry Murdoch have received an $89...dy the safe storage of carbon dioxide in geologica...e. , With carbon dioxide emissions from burning ...lobal warming, geologic storage of the gas is one ...issions using current technology. , "Geologic st...
Breaking Biology News(10 mins):Innovation puts next-generation solar cells on the horizon 2Loneliness can be contagious 2Loneliness can be contagious 3China Sky One Medical Inc Appoints New Independent Director 13412 1China Sky One Medical Inc Appoints New Independent Director 13412 2China Sky One Medical Inc Appoints New Independent Director 13412 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 1Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 2Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 4Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 5CSC to Help Georgia Hospital Association Members Achieve Meaningful Use of Electronic Health Records 53827 1CSC to Help Georgia Hospital Association Members Achieve Meaningful Use of Electronic Health Records 53827 2
...west National Laboratory scientists have used elec...molecules lasagna-like around spaghetti-like carbo... a wide range of applications, from ultra-precise ...on, said Yuehe Lin, who led the research at the De...l Molecular Sciences Laboratory. , The technique...
...Riverside have discovered a molecular mechanism di...al development. The findings could hold promise fo.... , The research is published in the Feb. 24 edit...ssor Frank Sauer, with German colleague Elisabeth ... in Munich, and fellow UCR researchers Tilman Sanc...
...er to survey the entire human genome and identify ...lex diseases, researchers at Johns Hopkins, togeth...ramingham Heart Study, U.S.A., have identified a g...art rhythms that lead to sudden cardiac death, a c...s each year. , The gene called NOS1AP, not previo...
Other Biology News:A biosensor layered like lasagna 2Researchers unlock how cells determine their functions 2Whole-genome study at Johns Hopkins reveals a new gene associated with abnormal heart rhythm 2Whole-genome study at Johns Hopkins reveals a new gene associated with abnormal heart rhythm 3
Experion Pro260 Reagents and Supplies, for 10 chips from Bio-Rad
...Staccato Mini-Workstations provide fast and reliab..., proteomics and drug development laboratories. St...of instrumentation to automate basic liquid handli...rkstations are controlled with either Caliper's ti...
Aldehyde Slides from Genetix
...The Experion system, 100-120 and 220-240 V, is a m...eps of gel-based electrophoresis, including some d...tion is used for protein analysis (it does not inc.... The system includes the electrophoresis station,...
Biology Products: